Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Securities Class Action Filing Deadline
RADNOR, PA–(NewMediaWire)–December 27, 2024–The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that against Kyverna Therapeutics, Inc. ) (NASDAQ: KYTX ) on behalf of those who purchased Kyverna common stock pursuant to and/or traceable to Kyverna’s initial public offering (IPO) on February 8, 2024. The deadline for the lead plaintiff is February 7, 2025.
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you have suffered losses from Kyverna, you can CLICK HERE or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
You may also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or emailing info@ktmc.com.
ALLEGED MISCONDUCT OF THE ACCUSED:
The complaint alleges that in the prospectus and registration statements issued in connection with the IPO, the defendants made materially false and/or misleading statements and/or omissions regarding the company’s business, operations and prospects. Specifically, Defendants made false and/or misleading statements regarding, and/or failed to disclose, that Kyverna possessed negative data regarding one of its clinical trials at the time of its IPO.
PROCEDURE OF THE CHIEF PROSECUTOR:
Kyverna investors may, no later than February 7, 2025, seek to be appointed as lead plaintiff, class representative through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. The lead plaintiff is the representative party that acts on behalf of all class members in the conduct of the litigation. The lead plaintiff is usually an investor or a small group of investors who have the greatest financial interest and who are also appropriate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and those attorneys, if approved by the court, are lead or class counsel. Deciding whether or not to be the lead claimant does not affect your ability to participate in the recovery.
Kessler Topaz Meltzer & Check, LLP encourages Kyverna investors who have suffered significant losses to contact the firm directly for more information.
CLICK HERE TO APPLY FOR A CASE OR COPY AND PASTE THIS LINK INTO YOUR BROWSER: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP litigates class actions in state and federal courts nationwide and around the world. The company has built a global reputation for excellence and has recovered billions of dollars from victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by companies and fiduciaries. The appeal in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP, visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
info@ktmc.com
May be considered solicitor advertising in certain jurisdictions. Past results do not guarantee future results.
See the original release at www.newmediawire.com
Copyright 2024 JCN Newswire. All rights reserved.
